Data With Novel Agents Prompt Treatment Sequencing Discussions in MCL and CLL

Catherine C. Coombs, MD, and Alexey Danilov, MD, PhD, moderate a discussion on the role and sequencing of BTK inhibitors, venetoclax-based regimens, and CAR T-cell therapy in mantle cell lymphoma and chronic lymphocytic leukemia.

Related Keywords

Germany ,University Of California Irvine ,California ,United States ,Tara Graff ,Mazyar Shadman ,Matthew Lunning ,Matthew Davids ,John Allan ,Catherinec Coombs ,Jakub Svoboda ,Deborah Stephens ,Brad Kahl ,Bijal Shah ,Alexey Danilov ,Catherine Coombs ,International Conference On Malignant Lymphoma ,Toni Stephenson Lymphoma Center ,Fred Hutch Cancer Center ,Dana Farber Cancer Institute ,Washington University ,University Of Utah Health ,City Of Hope National Medical Center ,Mission Blood ,University Of Nebraska Medical Center ,University Of California Irvine School Medicine ,Moffitt Cancer Center ,National Comprehensive Cancer Network ,Department Of Medicine ,Scientific Interchange ,California Irvine School ,Hope National Medical Center ,Moffitt Cancer ,Utah Health ,Nebraska Medical Center ,International Conference ,Malignant Lymphoma ,Continuous Therapy ,Weill Cornell Medicine ,Santa Monica Beach ,Penn Medicine ,Mantle Cell Lymphoma ,Chronic Lymphocytic Leukemia ,D ,Phd ,Role And Sequencing Of Btk Inhibitors ,Cart Cell Therapy In Mcl And Cll ,Venetoclax ,Msc ,O ,Naacp ,Bph ,Mission Blood And Cancer ,